Phase I clinical trial of an acellular pertussis vaccine composed of genetically detoxified pertussis toxin combined with FHA and 69 kDa

Authors:
  • LNLuciano Nencioni
    Luciano Nencioni
  • IMIlio Marsili
    Ilio Marsili
  • GVGianfranco Volpini
    Gianfranco Volpini
  • DDDonatella Donati
    Donatella Donati
  • ATAnnalisa Di Tommaso
    Annalisa Di Tommaso
  • MMMaria Teresa De Magistris
    Maria Teresa De Magistris
  • RRRino Rappuoli
    Rino Rappuoli

Abstract
No abstract available

This publication has 16 references indexed in Scilit: